pharma-company /Medicinal products /Active ingredients

Rx · PZN 18106584

TECENTRIQ 1875 mg solution for injection vial

German trade nameTECENTRIQ 1875 mg Injektionslösung Durchstechflasche

Active ingredientAtezolizumabPharmaceutical formSolution for injection/infusion

Available with fluctuations

3.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €3,351

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for TECENTRIQ 1875 mg solution for injection vial.

Review purchasing terms

TECENTRIQ 1875 mg solution for injection vial contains the active ingredient Atezolizumab and comes as Solution for injection/infusion. One pack size is recorded (PZN 18106584). The pharma availability index for German wholesale stands at 3.6 out of 10 over the past 30 days – the pack was therefore available with fluctuations.

Availability of TECENTRIQ 1875 mg solution for injection vial fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

More products containing Atezolizumab

TECENTRIQ 1200 mg concentrate for preparation of a solution for infusion vial6.4TECENTRIQ 840 mg concentrate for preparation of a solution for infusion vial2.9
Active ingredient overview: Atezolizumab →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.